(Q64103085)

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Platelet functions beyond hemostasis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Emerging roles for platelets as immune and inflammatory cells

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Platelets are not just for clots

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Thrombocytopenia: an update

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

1 reference

7 January 2021

Thrombocytosis and thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

1 reference

7 January 2021

Management of thrombocytopenia

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Platelet transfusion refractoriness

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Recent developments in ex vivo platelet production.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Translational approaches to functional platelet production ex vivo.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Megakaryopoiesis and thrombopoiesis: an update on cytokines and lineage surface markers

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Unraveling mechanisms that control platelet production

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

TPO-independent megakaryocytopoiesis.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

The incredible journey: From megakaryocyte development to platelet formation.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Neurotrophin-regulated signalling pathways

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Trk receptors: roles in neuronal signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

The neurotrophic factors in non-neuronal tissues

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Cardiovascular actions of neurotrophins

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

The neurotrophin family of neurotrophic factors: an overview

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Nerve growth factor promotes human hemopoietic colony growth and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Expression of neurotrophins and their receptors in human bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Nerve growth factor: a neurotrophin with activity on cells of the immune system

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Neurotrophins and B-cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Cross talk between neuroregulatory molecule and monocyte: nerve growth factor activates the inflammasome

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Nerve growth factor interactions with mast cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Neurotrophins modulate monocyte chemotaxis without affecting macrophage function.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Nerve growth factor influences IgE-mediated human basophil activation: functional properties and intracellular mechanisms compared with IL-3.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Anti-apoptotic effect of nerve growth factor is lost in congenital insensitivity to pain with anhidrosis (CIPA) B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Ablation of TrkA function in the immune system causes B cell abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Neurotrophins and the immune system

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Neurotrophins and cytokines--intermediaries between the immune and nervous systems

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Nerve growth factor potentiated the sodium butyrate- and PMA-induced megakaryocytic differentiation of K562 leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Induction of polyploidization in the human erythroleukemia cell line (HEL) by protein kinase inhibitor (K252a) and the phorbol-ester TPA.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

K-252a-induced polyploidization and differentiation of a human megakaryocytic cell line, Meg-J: transient elevation and subsequent suppression of cyclin B1 and cdc2 expression in the process of polyploidization

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Genome engineering using the CRISPR-Cas9 system

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Kinetics of trkA Tyrosine Kinase Activity and Inhibition by K-252a

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Production of functional platelet-like particles by the megakaryoblastic DAMI cell line provides a model for platelet biogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

K-252 compounds: modulators of neurotrophin signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Platelet formation: a link between apoptosis and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

A megakaryocyte with no platelets: anti-platelet antibodies, apoptosis, and platelet production

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Platelet formation is the consequence of caspase activation within megakaryocytes

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Megakaryocyte apoptosis: sorting out the signals

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Identification of the prosurvival activity of nerve growth factor on cardiac myocytes

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7/IGF-IR [corrected].

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

c-Src activation through a TrkA and c-Src interaction is essential for cell proliferation and hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Autocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Hypersensitivity of megakaryocyte progenitors to thrombopoietin in essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

The relationship between the myelodysplastic syndromes and the myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Developmental differences in megakaryocyte maturation are determined by the microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Safety and efficacy of thrombopoietin-receptor agonists in myelodysplastic syndromes: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Safety of platelet transfusion: past, present and future.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Problem of bacterial contamination in platelet concentrates

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Platelet transfusion: basic aspects

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Legal and ethical issues in safe blood transfusion

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Stem cells, megakaryocytes, and platelets

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Infusion of megakaryocytic progenitor products generated from cord blood hematopoietic stem/progenitor cells: results of the phase 1 study

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

In vitro generation of platelets through direct conversion: first report in My Knowledge (iMK).

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

NGF receptor TrkAd5: therapeutic agent and drug design target.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

TrkAd5: A novel therapeutic agent for treatment of inflammatory pain and asthma.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Novel class of pain drugs based on antagonism of NGF.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

Antidepressants and anti-inflammatory drugs differentially reduce the release of NGF and BDNF from rat platelets

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-39385-X

7 January 2021

K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors

1 reference

12 December 2020

K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity

1 reference

12 December 2020

Characterization of a new megakaryocytic cell line: the Dami cell

1 reference

12 December 2020

Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells.

1 reference

12 December 2020

Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues

1 reference

12 December 2020

Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis

1 reference

12 December 2020

Effect of nerve growth factor on erythropoiesis in mice and its underlying mechanism.

1 reference

12 December 2020

Managing thrombocytopenia associated with cancer chemotherapy

1 reference

12 December 2020